PTCH1 Gene Polymorphisms Linked to COPD Susceptibility in Chinese Han Population: A Case-Control Study
Chronic obstructive pulmonary disease (COPD) is a top global cause of death and disability, affecting over 300 million people—but why some individuals develop it while others don’t, even with similar exposures like smoking, remains a mystery. Genetics play a key role, and a 2020 study from Central South University in China is the first to link variants in the PTCH1 gene to COPD risk in the Chinese Han population, offering new clues about the disease’s origins.
What Is PTCH1 and Why Does It Matter?
The PTCH1 gene (located on chromosome 9q22) encodes Patched1, a protein critical to the Hedgehog signaling pathway—a system that shapes lung development before birth and repairs damage after injury. Think of Patched1 as a “gatekeeper”: when it binds to Hedgehog proteins, it triggers signals that guide lung growth. Mutations in PTCH1 can disrupt this process, potentially raising the risk of lung diseases like COPD.
Previous research in European populations tied PTCH1 variants to lower lung function and higher COPD risk. But genetic differences between ethnic groups mean these findings might not apply to Asians. The Chinese Han study fills this gap.
Study Design: Who Was Included?
The team—led by Dr. Hong Luo from the Second Xiangya Hospital of Central South University—recruited 296 people with stable COPD and 300 healthy controls, all Han Chinese from Hunan Province. COPD was diagnosed using GOLD criteria (the global standard for COPD care), and controls had normal lung function with no history of respiratory disease (e.g., asthma, tuberculosis).
Researchers analyzed 28 PTCH1 single-nucleotide polymorphisms (SNPs)—small, common genetic changes that can affect gene function. They used advanced sequencing to genotype participants and adjusted for age, gender, and smoking status to isolate genetic effects.
Key Findings: Which Variants Raise (or Lower) Risk?
Three PTCH1 SNPs were significantly associated with increased COPD risk:
- The “A” allele of rs28491365 (1.39x higher risk)
- The “G” allele of rs10512248 (1.30x higher risk)
- The “G” allele of rs28705285 (1.36x higher risk)
One SNP offered protection: People with the “T/T” genotype of rs34695652 were 51% less likely to develop COPD (after adjusting for confounders).
The team also looked at haplotypes—combinations of SNPs inherited together. The rs28504650/rs10512248 “CG” haplotype increased COPD risk by over 6x (OR: 6.36, 95% CI: 1.22–33.29).
Why These Results Matter
Most risk-linked SNPs are in introns—parts of the gene once dismissed as “junk DNA.” But research now shows introns regulate gene expression: variants like rs10512248 and rs28491365 might boost PTCH1 protein levels, disrupting the Hedgehog pathway and worsening lung damage. The protective rs34695652 is in the gene’s 5’ flanking region (which controls activation), so its “T/T” genotype could lower PTCH1 activity and reduce harm.
This is the first study to link PTCH1 variants to COPD in Chinese Han people. It confirms that the Hedgehog pathway plays a role in COPD across populations—but genetic risk factors vary by ethnicity.
Limitations to Consider
The study had small sample sizes, so researchers couldn’t explore interactions between genetics and smoking (a major COPD risk factor) or do age-stratified analysis (COPD patients were older than controls). They also didn’t test how these SNPs functionally change PTCH1—future work needs to confirm biological mechanisms.
What’s Next?
These findings add to our understanding of COPD’s genetic basis and highlight the need for population-specific research. Down the line, this could lead to personalized treatments: for example, targeting the Hedgehog pathway in people with high-risk PTCH1 variants.
The original study was published in the Chinese Medical Journal (2020) by Xi Kang, Ting Guo, Lyu Liu, Shui-Zi Ding, Cheng Lei, and Hong Luo from the Second Xiangya Hospital of Central South University. Funding came from the National Natural Science Foundation of China (grants 81470202, 81570288, 819000002) and Central South University’s Clinical Data System for Pulmonary Inflammatory Diseases.
doi.org/10.1097/CM9.0000000000000858
Was this helpful?
0 / 0